These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9221302)

  • 21. Class III Antiarrhythmics: put to the SWORD?
    Cobbe SM
    Heart; 1996 Feb; 75(2):111-3. PubMed ID: 8673743
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of ventricular tachycardia by sotalol in myotonic dystrophy.
    Cohen MB; Snow JS; Merkatz KA; Kholwadwala D; Jadonath RL; Goldner BG; Cohen TJ
    Am Heart J; 1996 Aug; 132(2 Pt 1):446-9. PubMed ID: 8701909
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment and prevention of sudden cardiac death: effect of recent clinical trials.
    Goldberger JJ
    Arch Intern Med; 1999 Jun; 159(12):1281-7. PubMed ID: 10386504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R
    Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
    Yap YG; Camm AJ
    Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
    Singh BN
    Heart Fail Rev; 2002 Jul; 7(3):285-300. PubMed ID: 12215733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolving role of sotalol in the management of ventricular tachyarrhythmias.
    O'Callaghan PA; McGovern BA
    Am J Cardiol; 1996 Aug; 78(4A):54-60. PubMed ID: 8780329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of beta blockade in the therapy of serious ventricular arrhythmias.
    Reiter MJ; Reiffel JA
    Am J Cardiol; 1998 Aug; 82(4A):9I-19I. PubMed ID: 9737650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical considerations in the use of sotalol for ventricular tachycardia and ventricular fibrillation.
    Campbell RW; Furniss SS
    Am J Cardiol; 1993 Aug; 72(4):80A-85A. PubMed ID: 8346732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
    Candinas R; Bauersfeld U
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug therapy of cardiac arrhythmias 199].
    Dietz A; Manz M
    Fortschr Med; 1997 Nov; 115(33):32, 34-6, 38. PubMed ID: 9480278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of drug therapy for sustained ventricular tachyarrhythmias.
    Mitchell LB
    Cardiol Clin; 2008 Aug; 26(3):405-18, vi. PubMed ID: 18538187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials.
    Farré J; Romero J; Rubio JM; Ayala R; Castro-Dorticós J
    Am J Cardiol; 1999 Mar; 83(5B):55D-63D. PubMed ID: 10089841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sotalol for cardiac arrhythmias.
    Med Lett Drugs Ther; 1993 Apr; 35(893):27-8. PubMed ID: 8450806
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacologic and nonpharmacologic treatment of ventricular arrhythmias in heart failure.
    Stevenson WG; Sweeney MO
    Curr Opin Cardiol; 1997 May; 12(3):242-50. PubMed ID: 9243081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.